Dr Mark Prentice

Job title

Consultant clinical oncologist

Qualifications

MBChB BSc MRCP FRCR AKC

GMC Number

6160554

Contact details

PA/secretary phone number: Angie Fisher - 020 7830 2169

PA/secretary email address: angie.fisher@nhs.net

Related services

Cancer services

Biography

Dr Mark Prentice specialises in uro-oncology - prostate, bladder and renal cancers - and is interested in novel radiotherapy techniques, radio-ligand therapy, the hormonal manipulation of prostate cancer and the management of older people with cancer. He is the principal investigator for multiple clinical trials and has written international guidelines on prostate cancer management.

Publications

Radical Prostate Radiotherapy and the Use of Androgen Deprivation in the Era of Risk Stratification; Does Real-World Practice Follow the Evidence? Prentice M. Mpima, S. Nasuti, P. & Payne, H. (2021) Journal of Clinical Oncology 39(suppl) 216

Neutrophil-to-lymphocyte ratio (NLR) as a prognostic indicator of treatment response to novel hormones in metastatic castrate-resistant prostate cancer: Real-world data from a single institution Scott, E. Pasciuti, K. Kubiak, M. Needleman, S. Marks. G, Smith, K & Prentice, M (2021) Journal of Clinical Oncology 39(suppl) 52

The Shift Towards Digital Appointments: the Response to COVID-19 Affecting Uro-Oncology Scott, E. Kubiak, M. Needleman, S. Marks. G, Smith, K & Prentice, M (2020) Clinical Oncology, On Line July 2020

Computer Modelling in Prostate Anti-Cancer Therapy Prentice, M. Mann, K. Payne, H.A. Wong, I –(2019) Journal of Clinical Oncology 37 Suppl (e16528) 2019

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older adults Boyle, H.J., Alibhai, S., Decoster, L., Efstathiou, E., Fizazi, K., Mottet, N., Oudard, S., Payne, H., Prentice, M., Puts, M., Aapro, M., Droz, J.-P. – Review and International Guidelines (2019) European Journal of Cancer, July 2019, 116: 116-136

Separation and Rectal Dosimetry With A Hydrogel Spacer Inserted During Prostate HDR Brachytherapy Radiotherapy and Oncology Davda, R. Pendse, D. Mitra, M. Prentice, M et al (2019) 133: S589-S590

Perspectives on Geriatric Oncology Research Presented at the 2019 American Society of Clinical Oncology Genitourinary Cancer Symposium (2019) Shen, J. Prentice, M. et al (2019) - Review, Journal of Geriatric Oncology 10(4) 523-525